薬剤一体型ポリマーファイバーのグローバル市場展望 2023年-2029年:ポリ乳酸、ポリジオキサノン、ポリカプロラクトン

■ 英語タイトル:Drug Integrated Polymer Fibers Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート(データ管理コード:MMG23LY8483)■ 発行会社/調査会社:Market Monitor Global
■ 商品コード:MMG23LY8483
■ 発行日:2023年7月
■ 調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野:医薬品&ヘルスケア
■ ページ数:77
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[薬剤一体型ポリマーファイバーのグローバル市場展望 2023年-2029年:ポリ乳酸、ポリジオキサノン、ポリカプロラクトン]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査レポートは次の情報を含め、世界の薬剤一体型ポリマーファイバー市場規模と予測を収録しています。・世界の薬剤一体型ポリマーファイバー市場:売上、2018年-2023年、2024年-2029年
・世界の薬剤一体型ポリマーファイバー市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の薬剤一体型ポリマーファイバー市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ポリ乳酸」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

薬剤一体型ポリマーファイバーのグローバル主要企業は、TissueGen、 Micro Engineering Solutions、 Integrated Polymer Solutionsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、薬剤一体型ポリマーファイバーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の薬剤一体型ポリマーファイバー市場:タイプ別、2018年-2023年、2024年-2029年
世界の薬剤一体型ポリマーファイバー市場:タイプ別市場シェア、2022年
・ポリ乳酸、ポリジオキサノン、ポリカプロラクトン

世界の薬剤一体型ポリマーファイバー市場:用途別、2018年-2023年、2024年-2029年
世界の薬剤一体型ポリマーファイバー市場:用途別市場シェア、2022年
・薬物送達、整形外科用縫合糸、血管ステント、血管移植片、真皮創傷治療

世界の薬剤一体型ポリマーファイバー市場:地域・国別、2018年-2023年、2024年-2029年
世界の薬剤一体型ポリマーファイバー市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における薬剤一体型ポリマーファイバーのグローバル売上、2018年-2023年
・主要企業における薬剤一体型ポリマーファイバーのグローバル売上シェア、2022年
・主要企業における薬剤一体型ポリマーファイバーのグローバル販売量、2018年-2023年
・主要企業における薬剤一体型ポリマーファイバーのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
TissueGen、 Micro Engineering Solutions、 Integrated Polymer Solutions

*************************************************************

・調査・分析レポートの概要
薬剤一体型ポリマーファイバー市場の定義
市場セグメント
世界の薬剤一体型ポリマーファイバー市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の薬剤一体型ポリマーファイバー市場規模
世界の薬剤一体型ポリマーファイバー市場規模:2022年 VS 2029年
世界の薬剤一体型ポリマーファイバー市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの薬剤一体型ポリマーファイバーの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の薬剤一体型ポリマーファイバー製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:ポリ乳酸、ポリジオキサノン、ポリカプロラクトン
薬剤一体型ポリマーファイバーのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:薬物送達、整形外科用縫合糸、血管ステント、血管移植片、真皮創傷治療
薬剤一体型ポリマーファイバーの用途別グローバル売上・予測

・地域別市場分析
地域別薬剤一体型ポリマーファイバー市場規模 2022年と2029年
地域別薬剤一体型ポリマーファイバー売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
TissueGen、 Micro Engineering Solutions、 Integrated Polymer Solutions
...

Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable polymers. These devices can be made from different materials and are available in custom sizes and shapes to meet specific biological requirements. With a rise in complexity along with technological innovations, textile devices are being designed to meet a broader range of applications than earlier which will boost the demand of drug integrated polymer fibers. Textiles are being considered as the logical choice for soft tissue repair including hernias, ligaments and tendons due to its fibrous nature of human body.
This report aims to provide a comprehensive presentation of the global market for Drug Integrated Polymer Fibers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Integrated Polymer Fibers. This report contains market size and forecasts of Drug Integrated Polymer Fibers in global, including the following market information:
Global Drug Integrated Polymer Fibers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drug Integrated Polymer Fibers Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Drug Integrated Polymer Fibers companies in 2022 (%)
The global Drug Integrated Polymer Fibers market was valued at US$ 58 million in 2022 and is projected to reach US$ 74 million by 2029, at a CAGR of 3.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Polylactic Acid Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drug Integrated Polymer Fibers include TissueGen, Micro Engineering Solutions and Integrated Polymer Solutions, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Integrated Polymer Fibers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Integrated Polymer Fibers Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Drug Integrated Polymer Fibers Market Segment Percentages, by Type, 2022 (%)
Polylactic Acid
Polydioxanone
Polycaprolactone
Global Drug Integrated Polymer Fibers Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Drug Integrated Polymer Fibers Market Segment Percentages, by Application, 2022 (%)
Drug Delivery
Orthopaedic Sutures
Vascular Stents
Vascular Grafts
Dermal Wound Healing
Global Drug Integrated Polymer Fibers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Drug Integrated Polymer Fibers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Integrated Polymer Fibers revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drug Integrated Polymer Fibers revenues share in global market, 2022 (%)
Key companies Drug Integrated Polymer Fibers sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Drug Integrated Polymer Fibers sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
TissueGen
Micro Engineering Solutions
Integrated Polymer Solutions
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drug Integrated Polymer Fibers, market overview.
Chapter 2: Global Drug Integrated Polymer Fibers market size in revenue and volume.
Chapter 3: Detailed analysis of Drug Integrated Polymer Fibers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drug Integrated Polymer Fibers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drug Integrated Polymer Fibers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次(コンテンツ)***

1 Introduction to Research & Analysis Reports
1.1 Drug Integrated Polymer Fibers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drug Integrated Polymer Fibers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drug Integrated Polymer Fibers Overall Market Size
2.1 Global Drug Integrated Polymer Fibers Market Size: 2022 VS 2029
2.2 Global Drug Integrated Polymer Fibers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drug Integrated Polymer Fibers Sales: 2018-2029
3 Company Landscape
3.1 Top Drug Integrated Polymer Fibers Players in Global Market
3.2 Top Global Drug Integrated Polymer Fibers Companies Ranked by Revenue
3.3 Global Drug Integrated Polymer Fibers Revenue by Companies
3.4 Global Drug Integrated Polymer Fibers Sales by Companies
3.5 Global Drug Integrated Polymer Fibers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drug Integrated Polymer Fibers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drug Integrated Polymer Fibers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drug Integrated Polymer Fibers Players in Global Market
3.8.1 List of Global Tier 1 Drug Integrated Polymer Fibers Companies
3.8.2 List of Global Tier 2 and Tier 3 Drug Integrated Polymer Fibers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drug Integrated Polymer Fibers Market Size Markets, 2022 & 2029
4.1.2 Polylactic Acid
4.1.3 Polydioxanone
4.1.4 Polycaprolactone
4.2 By Type – Global Drug Integrated Polymer Fibers Revenue & Forecasts
4.2.1 By Type – Global Drug Integrated Polymer Fibers Revenue, 2018-2023
4.2.2 By Type – Global Drug Integrated Polymer Fibers Revenue, 2024-2029
4.2.3 By Type – Global Drug Integrated Polymer Fibers Revenue Market Share, 2018-2029
4.3 By Type – Global Drug Integrated Polymer Fibers Sales & Forecasts
4.3.1 By Type – Global Drug Integrated Polymer Fibers Sales, 2018-2023
4.3.2 By Type – Global Drug Integrated Polymer Fibers Sales, 2024-2029
4.3.3 By Type – Global Drug Integrated Polymer Fibers Sales Market Share, 2018-2029
4.4 By Type – Global Drug Integrated Polymer Fibers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drug Integrated Polymer Fibers Market Size, 2022 & 2029
5.1.2 Drug Delivery
5.1.3 Orthopaedic Sutures
5.1.4 Vascular Stents
5.1.5 Vascular Grafts
5.1.6 Dermal Wound Healing
5.2 By Application – Global Drug Integrated Polymer Fibers Revenue & Forecasts
5.2.1 By Application – Global Drug Integrated Polymer Fibers Revenue, 2018-2023
5.2.2 By Application – Global Drug Integrated Polymer Fibers Revenue, 2024-2029
5.2.3 By Application – Global Drug Integrated Polymer Fibers Revenue Market Share, 2018-2029
5.3 By Application – Global Drug Integrated Polymer Fibers Sales & Forecasts
5.3.1 By Application – Global Drug Integrated Polymer Fibers Sales, 2018-2023
5.3.2 By Application – Global Drug Integrated Polymer Fibers Sales, 2024-2029
5.3.3 By Application – Global Drug Integrated Polymer Fibers Sales Market Share, 2018-2029
5.4 By Application – Global Drug Integrated Polymer Fibers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drug Integrated Polymer Fibers Market Size, 2022 & 2029
6.2 By Region – Global Drug Integrated Polymer Fibers Revenue & Forecasts
6.2.1 By Region – Global Drug Integrated Polymer Fibers Revenue, 2018-2023
6.2.2 By Region – Global Drug Integrated Polymer Fibers Revenue, 2024-2029
6.2.3 By Region – Global Drug Integrated Polymer Fibers Revenue Market Share, 2018-2029
6.3 By Region – Global Drug Integrated Polymer Fibers Sales & Forecasts
6.3.1 By Region – Global Drug Integrated Polymer Fibers Sales, 2018-2023
6.3.2 By Region – Global Drug Integrated Polymer Fibers Sales, 2024-2029
6.3.3 By Region – Global Drug Integrated Polymer Fibers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drug Integrated Polymer Fibers Revenue, 2018-2029
6.4.2 By Country – North America Drug Integrated Polymer Fibers Sales, 2018-2029
6.4.3 US Drug Integrated Polymer Fibers Market Size, 2018-2029
6.4.4 Canada Drug Integrated Polymer Fibers Market Size, 2018-2029
6.4.5 Mexico Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drug Integrated Polymer Fibers Revenue, 2018-2029
6.5.2 By Country – Europe Drug Integrated Polymer Fibers Sales, 2018-2029
6.5.3 Germany Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5.4 France Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5.5 U.K. Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5.6 Italy Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5.7 Russia Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5.8 Nordic Countries Drug Integrated Polymer Fibers Market Size, 2018-2029
6.5.9 Benelux Drug Integrated Polymer Fibers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drug Integrated Polymer Fibers Revenue, 2018-2029
6.6.2 By Region – Asia Drug Integrated Polymer Fibers Sales, 2018-2029
6.6.3 China Drug Integrated Polymer Fibers Market Size, 2018-2029
6.6.4 Japan Drug Integrated Polymer Fibers Market Size, 2018-2029
6.6.5 South Korea Drug Integrated Polymer Fibers Market Size, 2018-2029
6.6.6 Southeast Asia Drug Integrated Polymer Fibers Market Size, 2018-2029
6.6.7 India Drug Integrated Polymer Fibers Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drug Integrated Polymer Fibers Revenue, 2018-2029
6.7.2 By Country – South America Drug Integrated Polymer Fibers Sales, 2018-2029
6.7.3 Brazil Drug Integrated Polymer Fibers Market Size, 2018-2029
6.7.4 Argentina Drug Integrated Polymer Fibers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drug Integrated Polymer Fibers Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drug Integrated Polymer Fibers Sales, 2018-2029
6.8.3 Turkey Drug Integrated Polymer Fibers Market Size, 2018-2029
6.8.4 Israel Drug Integrated Polymer Fibers Market Size, 2018-2029
6.8.5 Saudi Arabia Drug Integrated Polymer Fibers Market Size, 2018-2029
6.8.6 UAE Drug Integrated Polymer Fibers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 TissueGen
7.1.1 TissueGen Company Summary
7.1.2 TissueGen Business Overview
7.1.3 TissueGen Drug Integrated Polymer Fibers Major Product Offerings
7.1.4 TissueGen Drug Integrated Polymer Fibers Sales and Revenue in Global (2018-2023)
7.1.5 TissueGen Key News & Latest Developments
7.2 Micro Engineering Solutions
7.2.1 Micro Engineering Solutions Company Summary
7.2.2 Micro Engineering Solutions Business Overview
7.2.3 Micro Engineering Solutions Drug Integrated Polymer Fibers Major Product Offerings
7.2.4 Micro Engineering Solutions Drug Integrated Polymer Fibers Sales and Revenue in Global (2018-2023)
7.2.5 Micro Engineering Solutions Key News & Latest Developments
7.3 Integrated Polymer Solutions
7.3.1 Integrated Polymer Solutions Company Summary
7.3.2 Integrated Polymer Solutions Business Overview
7.3.3 Integrated Polymer Solutions Drug Integrated Polymer Fibers Major Product Offerings
7.3.4 Integrated Polymer Solutions Drug Integrated Polymer Fibers Sales and Revenue in Global (2018-2023)
7.3.5 Integrated Polymer Solutions Key News & Latest Developments
8 Global Drug Integrated Polymer Fibers Production Capacity, Analysis
8.1 Global Drug Integrated Polymer Fibers Production Capacity, 2018-2029
8.2 Drug Integrated Polymer Fibers Production Capacity of Key Manufacturers in Global Market
8.3 Global Drug Integrated Polymer Fibers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drug Integrated Polymer Fibers Supply Chain Analysis
10.1 Drug Integrated Polymer Fibers Industry Value Chain
10.2 Drug Integrated Polymer Fibers Upstream Market
10.3 Drug Integrated Polymer Fibers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drug Integrated Polymer Fibers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(MMG23LY8483 )"薬剤一体型ポリマーファイバーのグローバル市場展望 2023年-2029年:ポリ乳酸、ポリジオキサノン、ポリカプロラクトン" (英文:Drug Integrated Polymer Fibers Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。